Investigation of hematological blood values in COVID-19 patients according to discharge and exitus groups

S. Erıten

Department of Emergency Medicine, Sultanbeyli State Hospital, Battalgazi, Sultanbeyli, Istanbul, Turkey. semiheriten@hotmail.com

---

• Hematology
• Infectious Diseases

OBJECTIVE: The investigation was conducted on hematological blood values examined in COVID-19 patients in order to assess whether these values could provide a prediction about the severity and course of the disease. In this way, the study aims to help determine the treatment plans of patients and monitor the recovery process with simple and common tests such as hematological blood values.

PATIENTS AND METHODS: This was a retrospective study. The study group consisted of patients with positive PCR test results registered in the Patient Automation System of the Emergency Department of Malatya Training and Research Hospital between 1 January and 30 April 2021. The patients were divided in discharge (n=187) and exitus (n=52) groups.

RESULTS: The study showed that Neutrophil (AUC=0.889, p<0.05), Lymphocyte (AUC=0.805, p<0.05) and mean corpuscular hemoglobin concentration (MCHC) (AUC=0.739, p<0.05) values may be a good predictive factor for disease severity and mortality risk of COVID-19 patients.

CONCLUSIONS: Neutrophil, Lymphocyte and MCHC blood test samples can be used as a biomarker in the effective fight against COVID-19.

Free PDF Download